| Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
 Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
 
  
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 
  free 
 Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
  free 
  free 
   English Wikipedia
 
 Nephropedia Template TP (
 
 Twit Text
 
 
 DeepDyve
 Pubget Overpricing
 | lüll   
 
 Aminoglycoside-induced mutation suppression (stop codon readthrough) as a  therapeutic strategy for Duchenne muscular dystrophy Malik V; Rodino-Klapac LR; Viollet L; Mendell JRTher Adv Neurol Disord  2010[Nov]; 3 (6): 379-89Duchenne muscular dystrophy (DMD) is the most common, lethal, X-linked genetic  disease, affecting 1 in 3500 newborn males. It is caused by mutations in the DMD  gene. Owing to the large size of the gene, the mutation rate in both germline and  somatic cells is very high. Nearly 13-15% of DMD cases are caused by nonsense  mutations leading to premature termination codons in the reading frame that  results in truncated dystrophin protein. Currently there is no cure for DMD. The  only available treatment is the use of glucocorticoids that have modest  beneficial effects accompanied by significant side effects. Different therapeutic  strategies have been developed ranging from gene therapy to exon skipping and  nonsense mutation suppression to produce the full-length protein. These  strategies have shown promise in the mdx mouse model of muscular dystrophy where  they have been reported to ameliorate the dystrophic phenotype and correct the  physiological defects in the membrane. Each of these molecular approaches are  being investigated in clinical trials. Here we review nonsense mutation  suppression by aminoglycosides as a therapeutic strategy to treat DMD with  special emphasis on gentamicin-induced readthrough of disease-causing premature  termination codons.ä
 |